Rothe A, Schulz H, Elter T, Engert A, Reiser M. Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin’s lymphoma. Haematologica [Internet]. 2004Jul.1 [cited 2026Nov.8];89(7):875-6. Available from: https://haematologica.org/article/view/3158